Chongqing Lummy Pharmaceutical (SZSE:300006) Total Liabilities : ¥854.3 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Total Liabilities?

Chongqing Lummy Pharmaceutical's Total Liabilities for the quarter that ended in Mar. 2024 was ¥854.3 Mil.

Chongqing Lummy Pharmaceutical's quarterly Total Liabilities declined from Sep. 2023 (¥787.82 Mil) to Dec. 2023 (¥768.71 Mil) but then increased from Dec. 2023 (¥768.71 Mil) to Mar. 2024 (¥854.30 Mil).

Chongqing Lummy Pharmaceutical's annual Total Liabilities increased from Dec. 2021 (¥714.65 Mil) to Dec. 2022 (¥870.22 Mil) but then declined from Dec. 2022 (¥870.22 Mil) to Dec. 2023 (¥768.71 Mil).

Chongqing Lummy Pharmaceutical Total Liabilities Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Total Liabilities Chart

Chongqing Lummy Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,847.70

1,924.79

714.65

870.22

768.71

Chongqing Lummy Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															902.18	816.49	787.82	768.71	854.30

Chongqing Lummy Pharmaceutical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Chongqing Lummy Pharmaceutical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	562.272	+	(129.027	+	77.415
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	768.7

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2890.88	-	2122.166
	=	768.7

Chongqing Lummy Pharmaceutical's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	686.164	+	(91.021	+	77.111
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	854.3

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2976.493	-	2122.197
	=	854.3

Chongqing Lummy Pharmaceutical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Lummy Pharmaceutical (SZSE:300006) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Yuma Road, Nan'an District, chongqing, CHN, 401123

Website

http://www.cqlummy.com

Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.

Executives

Yuan Yuan	Supervisors
Qiu Yu	Directors, executives
Leng Xue Feng	Secretary, Director
Zhang Xiao Xue	Supervisors
Wang Ying	Director
Zhou Xue Mei	Supervisors
Zhao Bin	Executives
Tang Xiao Hai	Executives
Fu Rong	Executives
Li Xian Feng	Supervisors
Qiu Wei	Director

Chongqing Lummy Pharmaceutical (SZSE:300006) Headlines

No Headlines